FDA Approves Agilent’s NSCLC Liquid Biopsy Companion Diagnostic Test
Agilent Technologies announced that the FDA has approved the ctDx FIRST as a companion diagnostic to identify advanced NSCLC.
Read More
Search Results for: lung cancer
FDA Approves Thermo Fisher CDx for ENHERTU Targeted NSCLC Therapy
ENHERTU is a specifically engineered HER2 directed antibody drug conjugate developed and commercialized by Daiichi Sankyo and AstraZeneca.
Read More
BillionToOne Launches Oncology Liquid Biopsy Products
BillionToOne announced the launch of its first oncology liquid biopsy products, Northstar Select and Northstar Response.
Read More
FDA Approves FoundationOne CDx as Companion Diagnostic for EGFR Therapeutics
Foundation Medicine’s tissue-based test is a genomic profiling test approved as a companion diagnostic for a group of targeted therapies.
Read More
Tribun Health Launches AI Computational Pathology Solution
The latest version of Tribun Health’s CaloPix 5 is an AI-powered computational pathology solution for diagnostics, prognosis, and drug development.
Read More